Immunohistochemistry of atrial and brain natriuretic peptides in control cats and cats with hypertrophic cardiomyopathy
Biondo, A.W.; Ehrhart, E.J.; Sisson, D.D.; Bulmer, B.J.; De Morais, H.S.A.; Solter, P.F.
Veterinary Pathology 40(5): 501-506
2003
ISSN/ISBN: 0300-9858
PMID: 12949406
DOI: 10.1354/vp.40-5-501
Accession: 003803466
Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are cardiac hormones involved in electrolyte and fluid homeostasis. Our laboratory has investigated the use of ANP and BNP as diagnostic markers of cardiac disease in cats. We hypothesize that the cardiac distribution of ANP and BNP increases in cats with hypertrophic cardiomyopathy (HCM).
PDF emailed within 0-6 h: $19.90
Related References
MacLean, H.N.; Abbott, J.A.; Ward, D.L.; Huckle, W.R.; Sisson, D.D.; Pyle, R.Lee. 2006: N-terminal atrial natriuretic peptide immunoreactivity in plasma of cats with hypertrophic cardiomyopathy Journal of Veterinary Internal Medicine 20(2): 284-289Briguori, C.; Betocchi, S.; Russo, R.; Manganelli, F.; Gottilla, R.; Ciampi, Q.; Losi, M.A.; Pezzella, E.; Volpe, M.; Chiariello, M. 1999: Determinants and clinical significance of atrial and brain natriuretic peptides in hypertrophic cardiomyopathy Journal of the American College of Cardiology 33(2 Suppl A): 508A
Wess, G.; Daisenberger, P.; Mahling, M.; Hirschberger, J.; Hartmann, K. 2011: Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats Veterinary Clinical Pathology 40(2): 237-244
Sugimoto, K.; Aoki, T.; Fujii, Y. 2020: Effects of atenolol on left atrial and left ventricular function in healthy cats and in cats with hypertrophic cardiomyopathy Journal of Veterinary Medical Science 82(5): 546-552
Koffas, H.; Dukes-McEwan, J.; Corcoran, B.M.; Moran, C.M.; French, A.; Sboros, V.; Simpson, K.; McDicken, W.N. 2006: Pulsed tissue Doppler imaging in normal cats and cats with hypertrophic cardiomyopathy Journal of Veterinary Internal Medicine 20(1): 65-77
Koffas, H.; Dukes-McEwan, J.; Corcoran, B.M.; Moran, C.M.; French, A.; Sboros, V.; Simpson, K.; Anderson, T.; McDicken, W.N. 2008: Colour M-mode tissue Doppler imaging in healthy cats and cats with hypertrophic cardiomyopathy Journal of Small Animal Practice 49(7): 330-338
Bédard, C.; Lanevschi-Pietersma, A.; Dunn, M. 2007: Evaluation of coagulation markers in the plasma of healthy cats and cats with asymptomatic hypertrophic cardiomyopathy Veterinary Clinical Pathology 36(2): 167-172
Jackson, B.L.; Lehmkuhl, L.B.; Adin, D.B. 2014: Heart rate and arrhythmia frequency of normal cats compared to cats with asymptomatic hypertrophic cardiomyopathy Journal of Veterinary Cardiology: the Official Journal of the European Society of Veterinary Cardiology 16(4): 215-225
Riesen, S.C.; Schober, K.E.; Smith, D.N.; Otoni, C.C.; Li, X.; Bonagura, J.D. 2012: Effects of ivabradine on heart rate and left ventricular function in healthy cats and cats with hypertrophic cardiomyopathy American Journal of Veterinary Research 73(2): 202-212
Yang, V.K.; Freeman, L.M.; Rush, J.E. 2008: Comparisons of morphometric measurements and serum insulin-like growth factor concentration in healthy cats and cats with hypertrophic cardiomyopathy American Journal of Veterinary Research 69(8): 1061-1066
Fox, P.R.; Keene, B.W.; Lamb, K.; Schober, K.E.; Chetboul, V.ér.; Luis Fuentes, V.; Payne, J.R.; Wess, G.; Hogan, D.F.; Abbott, J.A.; Häggström, J.; Culshaw, G.; Fine-Ferreira, D.; Cote, E.; Trehiou-Sechi, E.; Motsinger-Reif, A.A.; Nakamura, R.K.; Singh, M.; Ware, W.A.; Riesen, S.C.; Borgarelli, M.; Rush, J.E.; Vollmar, A.; Lesser, M.B.; Van Israel, N.; Lee, P.M.-S.; Bulmer, B.; Santilli, R.; Bossbaly, M.J.; Quick, N.; Bussadori, C.; Bright, J.; Estrada, A.H.; Ohad, D.G.; Del Palacio, M.J.F.án.; Brayley, J.L.; Schwartz, D.S.; Gordon, S.G.; Jung, S.; Bove, C.M.; Brambilla, P.G.; Moïse, N.S.; Stauthammer, C.; Quintavalla, C.; Manczur, F.; Stepien, R.L.; Mooney, C.; Hung, Y.-W.; Lobetti, R.; Tamborini, A.; Oyama, M.A.; Komolov, A.; Fujii, 2019: Long-term incidence and risk of noncardiovascular and all-cause mortality in apparently healthy cats and cats with preclinical hypertrophic cardiomyopathy Journal of Veterinary Internal Medicine 33(6): 2572-2586
MacDonald, K.A.; Wisner, E.R.; Larson, R.F.; Klose, T.; Kass, P.H.; Kittleson, M.D. 2005: Comparison of myocardial contrast enhancement via cardiac magnetic resonance imaging in healthy cats and cats with hypertrophic cardiomyopathy American Journal of Veterinary Research 66(11): 1891-1894
Riesen, S.C.; Schober, K.E.; Bonagura, J.D.; Carnes, C.A. 2013: Myocardial expression of hyperpolarization-activated, cyclic nucleotide-gated proteins in healthy cats and cats with hypertrophic cardiomyopathy Schweizer Archiv für Tierheilkunde 155(2): 143-147
Lalor, S.M.; Connolly, D.J.; Elliott, J.; Syme, H.M. 2009: Plasma concentrations of natriuretic peptides in normal cats and normotensive and hypertensive cats with chronic kidney disease Journal of Veterinary Cardiology: the Official Journal of the European Society of Veterinary Cardiology 11(Suppl 1): S71-S79
Hori, Y.; Yamano, S.; Iwanaga, K.; Kano, T.; Tanabe, M.; Uechi, M.; Kanai, K.; Nakao, R.; Hoshi, F.; Higuchi, S. 2008: Evaluation of plasma C-terminal atrial natriuretic peptide in healthy cats and cats with heart disease Journal of Veterinary Internal Medicine 22(1): 135-139
Ripoll Vera, T.ás.; Monserrat Iglesias, L.; Hermida Prieto, M.; Ortiz, M.; Rodriguez Garcia, I.; Govea Callizo, N.; Gómez Navarro, C.; Rosell Andreo, J.; Gámez Martínez, J.é M.ía.; Pons Lladó, G.; Cremer Luengos, D.; Torres Marqués, J. 2010: The R820W mutation in the MYBPC3 gene, associated with hypertrophic cardiomyopathy in cats, causes hypertrophic cardiomyopathy and left ventricular non-compaction in humans International Journal of Cardiology 145(2): 405-407
Meurs, K.M.; Norgard, M.M.; Kuan, M.; Haggstrom, J.; Kittleson, M. 2009: Analysis of 8 sarcomeric candidate genes for feline hypertrophic cardiomyopathy mutations in cats with hypertrophic cardiomyopathy Journal of Veterinary Internal Medicine 23(4): 840-843
MacDonald, K.A.; Kittleson, M.D.; Garcia-Nolen, T.; Larson, R.F.; Wisner, E.R. 2006: Tissue Doppler imaging and gradient echo cardiac magnetic resonance imaging in normal cats and cats with hypertrophic cardiomyopathy Journal of Veterinary Internal Medicine 20(3): 627-634
Golden, A.L.; Bright, J.M. 1990: Use of relaxation half-time as an index of ventricular relaxation in clinically normal cats and cats with hypertrophic cardiomyopathy American Journal of Veterinary Research 51(9): 1352-1356
De Lima, G.V.; Ferreira, F.d.S. 2017: N-terminal-pro brain natriuretic peptides in dogs and cats: a technical and clinical review Veterinary World 10(9): 1072-1082